San Francisco-based Invitae has developed a genetic testing service that aims to offer an alternative to home-based testing kits or expensive testing by a doctor. Invitae's offering will combine both approaches by providing at-home clinical-grade testing, along with the involvement of a doctor or genetic counsellor, who will convert the results into meaningful information for the patient. The company is currently working on its first product, which it hopes to launch in early 2016.
San Francisco-based Invitae has developed a genetic testing service that aims to offer an alternative to home-based testing kits or expensive testing by a doctor. Invitae's offering will combine both approaches by providing at-home clinical-grade testing, along with the involvement of a doctor or genetic counsellor, who will convert the results into meaningful information for the patient. Meanwhile, Color Genomics has launched a similar service, Nebula Genomics enables people to earn cryptocurrency by sharing their data, and LunaDNA buys genetic data from the patient.